Project Grant K23DA060412
Award Date
5/15/25
Completion Date
4/30/30
Dollars Obligated
$201K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This $1,607,146 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development of community-based technology interventions to encourage drug checking, distribution of harm reduction supplies, and linkage to substance use disorder treatment services. The recipient, NDRI-USA Inc., a non-profit research organization, will use a participatory design process to create multimedia content in English...
This federal Project Grant award of $4,920,000.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to investigate the feasibility, acceptability, and effectiveness of using long-acting injectable naltrexone as a preventive measure for opioid overdose among individuals using stimulants and living with or at risk of HIV. The 4-year study, running from July 1, 2024 to June 30, 2028, will be conducted at the University of...
This Project Grant award of $424,545.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a national survey on naloxone use and access. The goals of this 2-year project are to provide timely evidence on the state of naloxone carrying in the U.S., including monitoring the impact of the recent over-the-counter (OTC) naloxone product approvals. The project will examine barriers to naloxone purchasing and possession, such as...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $3,067,394 from September 30, 2024 to August 31, 2026 to The University of Kentucky Research Foundation. The funded project will test an innovative, peer-driven "intravention" approach to reduce the risk of overdose, hepatitis C, skin and soft tissue infections, and HIV among people who use drugs in two rural Kentucky counties...
This Project Grant award of $610,092 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will develop and evaluate a hybrid substance use prevention program for upper elementary school students. The program will utilize both online e-learning modules and traditional classroom sessions to teach students about the harms of vaping and prescription drug misuse, while enhancing protective factors by building social and self-regulation...
The National Institute on Drug Abuse (NIDA) awarded a $390,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Regents of the University of Michigan. The grant, titled "Cultivating Recovery: A Pilot Study of Digital Contingency Management for Co-Occurring Opioid and Alcohol Use Disorder," will fund a mixed-methods randomized pilot trial to test the feasibility and acceptability of a digital contingency management intervention for Medicaid...
This $2,316,128 federal Project Grant award, with a completion date of July 31, 2028, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to design tailored harm reduction strategies that effectively address the heterogeneous nature of overdose epidemics, demographics, and local infrastructures across six distinct jurisdictions. The grantee, the Regents of the University of Minnesota, will collaborate with...
This National Institute on Drug Abuse (NIDA) K01 award provides $194,098 to Dr. Erath at the University of Vermont to gain expertise in implementation science and advance the use of contingency management (CM), an evidence-based treatment for stimulant use disorder (StimUD), in community harm reduction settings. The key products and services to be delivered under this 4.5-year Project Grant are: 1) Qualitative research examining contextual factors for implementing CM for StimUD in syringe...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to address racial disparities in opioid overdose deaths. The $451,962 grant, awarded on July 1, 2024, supports the development and evaluation of a multimodal intervention consisting of an AI-driven texting tool and peer recovery coach (PRC) telephone-based services coordination for Black and Latinx people who use opioids. The key products and services to...
This $180,896 federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to use machine learning techniques to analyze integrated clinical and geosocial data to inform the design of a clinical decision support system (CDSS) to reduce the risk of stimulant therapy. The key products/services to be delivered under this 5-year award, starting July 2024, include: Retrospective analysis of electronic...